Compare MEDINOVA DIA with - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

MEDINOVA DIAG. vs DR. LAL PATHLABS - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    MEDINOVA DIAG. DR. LAL PATHLABS MEDINOVA DIAG./
DR. LAL PATHLABS
 
P/E (TTM) x 12.4 73.4 16.8% View Chart
P/BV x - 25.0 - View Chart
Dividend Yield % 0.0 0.6 -  

Financials

 MEDINOVA DIAG.   DR. LAL PATHLABS
EQUITY SHARE DATA
    MEDINOVA DIAG.
Mar-21
DR. LAL PATHLABS
Mar-21
MEDINOVA DIAG./
DR. LAL PATHLABS
5-Yr Chart
Click to enlarge
High Rs312,735 1.1%   
Low Rs111,305 0.9%   
Sales per share (Unadj.) Rs12.8189.7 6.7%  
Earnings per share (Unadj.) Rs1.935.6 5.4%  
Cash flow per share (Unadj.) Rs2.644.8 5.9%  
Dividends per share (Unadj.) Rs020.00 0.0%  
Avg Dividend yield %01.0 0.0%  
Book value per share (Unadj.) Rs-7.2144.6 -5.0%  
Shares outstanding (eoy) m9.9883.34 12.0%   
Bonus / Rights / Conversions ---  
Price / Sales ratio x1.710.6 15.6%   
Avg P/E ratio x11.156.8 19.5%  
P/CF ratio (eoy) x8.145.1 17.9%  
Price / Book Value ratio x-2.914.0 -21.0%  
Dividend payout %056.2 0.0%   
Avg Mkt Cap Rs m211168,365 0.1%   
No. of employees `000NANA-   
Total wages/salary Rs m172,737 0.6%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m12715,813 0.8%  
Other income Rs m1513 0.3%   
Total revenues Rs m12916,326 0.8%   
Gross profit Rs m304,363 0.7%  
Depreciation Rs m7772 0.9%   
Interest Rs m5160 2.9%   
Profit before tax Rs m203,944 0.5%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1979 0.1%   
Profit after tax Rs m192,965 0.6%  
Gross profit margin %23.627.6 85.5%  
Effective tax rate %2.924.8 11.8%   
Net profit margin %14.918.7 79.7%  
BALANCE SHEET DATA
Current assets Rs m1611,452 0.1%   
Current liabilities Rs m802,743 2.9%   
Net working cap to sales %-50.255.1 -91.2%  
Current ratio x0.24.2 4.7%  
Inventory Days Days1921 89.6%  
Debtors Days Days18815 1,222.0%  
Net fixed assets Rs m254,881 0.5%   
Share capital Rs m100833 11.9%   
"Free" reserves Rs m-17211,219 -1.5%   
Net worth Rs m-7212,053 -0.6%   
Long term debt Rs m331 2,752.1%   
Total assets Rs m4116,333 0.2%  
Interest coverage x5.225.6 20.4%   
Debt to equity ratio x-0.50 -460,821.7%  
Sales to assets ratio x3.11.0 322.7%   
Return on assets %58.019.1 303.3%  
Return on equity %-26.524.6 -107.6%  
Return on capital %-61.834.0 -181.5%  
Exports to sales %00-   
Imports to sales %00.7 0.0%   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNA105 0.0%   
Fx inflow Rs m0143 0.0%   
Fx outflow Rs m0105 0.0%   
Net fx Rs m038 0.0%   
CASH FLOW
From Operations Rs m193,982 0.5%  
From Investments Rs m-3-2,120 0.1%  
From Financial Activity Rs m-14-1,386 1.0%  
Net Cashflow Rs m2476 0.5%  

Share Holding

Indian Promoters % 62.1 55.2 112.5%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.0 32.6 -  
FIIs % 0.0 26.8 -  
ADR/GDR % 0.0 0.0 -  
Free float % 37.9 44.8 84.6%  
Shareholders   9,804 125,953 7.8%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare MEDINOVA DIAG. With:   KAYA  GIAN LIFE CARE  CHOKSI LAB.  LOTUS EYE CARE  FORTIS HEALTHCARE  



Today's Market

SGX Nifty Up 114 Points, FabIndia IPO, Tanla Platforms' Partnership with Vodafone Idea, and Buzzing Stocks Today(Pre-Open)

Indian share markets ended on a strong note yesterday. Benchmark indices snapped two days of losses and witnessed sharp gains as globally fears of a significant impact on economic.

Related Views on News

DR. LAL PATHLABS 2020-21 Annual Report Analysis (Annual Result Update)

Aug 12, 2021 | Updated on Aug 12, 2021

Here's an analysis of the annual report of DR. LAL PATHLABS for 2020-21. It includes a full income statement, balance sheet and cash flow analysis of DR. LAL PATHLABS. Also includes updates on the valuation of DR. LAL PATHLABS.

DR. LAL PATHLABS Announces Quarterly Results (1QFY22); Net Profit Up 370.8% (Quarterly Result Update)

Aug 3, 2021 | Updated on Aug 3, 2021

For the quarter ended June 2021, DR. LAL PATHLABS has posted a net profit of Rs 1 bn (up 370.8% YoY). Sales on the other hand came in at Rs 6 bn (up 128.0% YoY). Read on for a complete analysis of DR. LAL PATHLABS's quarterly results.

5 Indian Companies Embracing Blockchain Technology (Views On News)

Nov 23, 2021

Blockchain adoption in India was slow in the past. Now, the technology is being well received.

From Paytm to Reliance Power: Big IPOs with the Worst Debut Day Performance (Views On News)

Nov 22, 2021

Paytm's flop show should not come as a surprise. This is not the first time a high-profile IPO has eroded investors' wealth on listing day.

Top 5 Stocks in which FIIs Sequentially Raised their Stakes (Views On News)

Oct 26, 2021

FIIs have largely stayed on the sidelines this month, booking profits at every opportunity they get, amid tapering concerns.

More Views on News

Most Popular

Infosys vs TCS: Which is Better?(Views On News)

Nov 26, 2021

In the post pandemic era, the top two IT companies in India are fighting to capture the growing demand for IT.

6 Popular Stocks that Turned into Penny Stocks(Views On News)

Nov 27, 2021

A look at popular stocks that crashed big time and never recovered, i.e. which went from 'Multibaggers to Multibeggers'.

India's Top 5 Monopoly Stocks to Watch Out for(Views On News)

Nov 30, 2021

These 5 companies dominate their sectors with a huge piece of the pie.

6 Penny Stocks that Rallied 1,000%+ in One Year(Views On News)

Dec 6, 2021

These penny stocks shed their penny status by surging 1,000% or more in the last one year.

The Biggest Winners and Losers in India's Transition to Electric Vehicles(Profit Hunter)

Nov 26, 2021

How India's EV transition could be a major headwind for the incumbents.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

MEDINOVA DIAG. SHARE PRICE


Dec 8, 2021 09:12 AM

TRACK MEDINOVA DIAG.

  • Track your investment in MEDINOVA DIAG. with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON MEDINOVA DIAG.

MEDINOVA DIAG. - LOOKS HEALTH SERVICES COMPARISON

COMPARE MEDINOVA DIAG. WITH

MARKET STATS